Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 12:03 AM
NCT ID:
NCT07154758
Eligibility Criteria:
Inclusion Criteria:
* Registration in SwedeHF with an index date after January 1st 2023 for the screening arm. For controls, hospital access after January 1st 2023.
* HF duration \>6 months to ensure that patients had time to go through the treatment optimization process as recommended by the guidelines.
* HF with reduced EF (HFrEF) defined as categorical or continuous EF ≤40%
* Capable of giving signed informed consent (for the screening arm)
Exclusion Criteria:
* Under optimization of HF therapy
* In judgment of the investigator unlikely to understand or comply with study procedures
Control population is sex and age matched with the SwedeHF screening arm (1:1)
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07154758
Study Brief:
Protocol Section:
NCT07154758